Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Progen Pharmaceuticals.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Progen Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00130442
First received: August 12, 2005
Last updated: March 2, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2008
  Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)